StockData

Data I/O vs inTEST

DAIO and INTT side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DAIO and INTT compare

inTEST is the larger company, worth 6.6 times as much as Data I/O ($176M against $26.6M).

inTEST grew revenue faster over the last twelve months (16.6% versus −24.0% for Data I/O).

inTEST keeps more of each dollar of sales as profit, with a net margin of 2.7% compared with −59.4% at Data I/O.

inTEST scores higher on the StockData Score (11 against 9 for Data I/O), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDAIOINTT
Size and price
Market cap$26.6M$176M
Share price$2.56$13.73
Change, 1 year−8.6%64.6%
Change, 5 years−47.4%−12.9%
Beta (5Y)0.861.36
Employees97407
StockData Score
Total score911 (better)
Valuation score3 (better)1
Growth score13 (better)
Performance score02 (better)
Health score55
Dividend score00
Valuation
P/E–45.8×
P/S1.5×1.3× (better)
P/B1.6×1.6× (better)
EV/EBITDA–14.6×
FCF yield−32.6%−0.14% (better)
Fair value$4.00$11.64
Margin of safety36.1% (better)−17.9%
Growth
Revenue growth (TTM)−24.0%16.6% (better)
Revenue growth, 5Y average1.1%16.2% (better)
Profitability
Gross margin52.7% (better)44.2%
Operating margin−48.7%3.3% (better)
Net margin−59.4%2.7% (better)
FCF margin−50.3%−0.17% (better)
Return on equity−63.7%3.5% (better)
Return on invested capital−101%4.0% (better)
Financial health
Debt / equity0.000.05 (better)
Net debt / EBITDA–−1.39
Interest coverage–13.3×
Current ratio3.43 (better)2.63
Altman Z-score1.424.48 (better)
Piotroski F-score35 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions29.9%67.3%
Held by insiders19.9%5.7%
Insider net buying, 12 months$1000K (better)−$57.8K
Short interest, % of float0.14%2.8%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.